Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period

被引:89
作者
Bortolotti, F
Jara, P
Crivellaro, C
Hierro, L
Cadrobbi, P
Frauca, E
Camarena, C
De La Vega, A
Diaz, C
De Moliner, L
Noventa, F
机构
[1] Univ Padua, Clin Med 5, Dipartimento Med Clin & Sperimentale, I-35100 Padua, Italy
[2] Padua Hosp, Dept Infect Dis, Padua, Italy
[3] Hosp Infantil La Paz, Hepatol Unit, Madrid, Spain
关键词
anti-HBe positive hepatitis; cirrhosis; hepatitis B virus infection; prognosis of hepatitis B; reactivation of hepatitis B;
D O I
10.1016/S0168-8278(98)80002-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Chronic hepatitis B virus infection can lead to cirrhosis and hepatocellular carcinoma, particularly in men over 40 years of age and in areas where childhood-onset infection is common. The sequence of events from paediatric infection to severe disease in adults is only partially known. The aim of this study was to evaluate the evolution of chronic hepatitis B acquired in childhood during 20 years of follow-up. Patients: One hundred and eighty-five consecutive, otherwise healthy, Caucasian children were enrolled in Padua (Italy) and in Madrid (Spain) between 1975 and 1985, and followed for an average period of 13 years; 168 mere hepatitis B e antigen (HBeAg) positive and five had cirrhosis. Results: Thirty patients received steroids or levamisole and 21 interferon, but treatment did not significantly influence HBeAg clearance. Overall, two (1.1%) children, with initial cirrhosis, developed hepatocellular carcinoma and the other three (1.6%) cirrhotic patients became asymptomatic carriers of infection after anti-HBe seroconversion and biochemical remission; 14 (7.5%) children maintained HBeAg positive hepatitis; 155 (83.8%) became asymptomatic carriers of infection after anti-HBe seroconversion and biochemical remission; sis (3.2%) experienced reactivation of liver disease and viral replication after remission and five (2.7%) maintained biochemical features of liver damage after HBeAg clearance. Only 6% cleared hepatitis B surface antigen. Conclusions: Even considering the bias of treatment, the large majority of Caucasian children with chronic hepatitis B became asymptomatic carriers of infection with normal alanine amino-transferase during the first 20 years of observation. Cirrhosis is an early, rare complication, and a risk factor for hepatocellular carcinoma. A subgroup of patients who experienced reactivation or maintained liver damage after HBeAg clearance seems to be at greater risk for disease progression during adult life.
引用
收藏
页码:184 / 190
页数:7
相关论文
共 19 条
  • [1] BARBERA C, 1994, HEPATOLOGY, V20, P287, DOI 10.1016/0270-9139(94)90175-9
  • [2] BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO
  • [3] 2-J
  • [4] LIVER-CIRRHOSIS ASSOCIATED WITH CHRONIC HEPATITIS-B VIRUS-INFECTION IN CHILDHOOD
    BORTOLOTTI, F
    CALZIA, R
    CADROBBI, P
    GIACCHINI, R
    CIRAVEGNA, B
    ARMIGLIATO, M
    PISCOPO, R
    REALDI, G
    [J]. JOURNAL OF PEDIATRICS, 1986, 108 (02) : 224 - 227
  • [5] CHRONIC HEPATITIS-B ACQUIRED IN CHILDHOOD - UNANSWERED QUESTIONS AND EVOLVING ISSUES
    BORTOLOTTI, F
    [J]. JOURNAL OF HEPATOLOGY, 1994, 21 (05) : 904 - 909
  • [6] CHANGES IN HEPATITIS-BE ANTIGEN-ANTIBODY SYSTEM IN CHILDREN WITH CHRONIC HEPATITIS-B VIRUS-INFECTION
    BORTOLOTTI, F
    CADROBBI, P
    CRIVELLARO, C
    ALBERTI, A
    RUGGE, M
    BERTAGGIA, A
    REALDI, G
    [J]. JOURNAL OF PEDIATRICS, 1983, 103 (05) : 718 - 722
  • [7] LONG-TERM OUTCOME OF CHRONIC TYPE-B HEPATITIS IN PATIENTS WHO ACQUIRE HEPATITIS-B VIRUS-INFECTION IN CHILDHOOD
    BORTOLOTTI, F
    CADROBBI, P
    CRIVELLARO, C
    GUIDO, M
    RUGGE, M
    NOVENTA, F
    CALZIA, R
    REALDI, G
    [J]. GASTROENTEROLOGY, 1990, 99 (03) : 805 - 810
  • [8] A NEW HEPATITIS-B VIRUS-STRAIN IN PATIENTS WITH SEVERE ANTI-HBE POSITIVE CHRONIC HEPATITIS-B
    BRUNETTO, MR
    STEMLER, M
    BONINO, F
    SCHODEL, F
    OLIVERI, F
    RIZZETTO, M
    VERME, G
    WILL, H
    [J]. JOURNAL OF HEPATOLOGY, 1990, 10 (02) : 258 - 261
  • [9] BRUNETTO MR, 1989, ITAL J GASTROENTEROL, V21, P151
  • [10] CARMAN WF, 1989, LANCET, V2, P588